| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.33 | 0.06 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.059 | 0.06 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.06 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | 0.062 | 0.06 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |